Interface Biologics logo

Interface Biologics

6 employees · est. 2001 · Toronto, Canada

VS
TargED Biopharmaceuticals logo

TargED Biopharmaceuticals

Targeted Enzyme Delivery to improve thrombolysis

27 employees · est. 2018 · Utrecht, The Netherlands

Interface Biologics is the older company (2001 vs 2018); TargED Biopharmaceuticals is the larger of the two.

Side-by-Side Comparison

Interface Biologics TargED Biopharmaceuticals
Founded
2001 older 2018
Headquarters
Toronto, Canada Utrecht, The Netherlands
Employees
6 27 larger
Industry
Biotechnology, Health Care, Medical Devices Biopharma, Biotechnology, Health Care
Funding Stage
Series B Series A
Total Funding
$32.00M $61.85M
Funding Rounds
6 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biomedical Polymer Technology, Anti-thrombogenic Additives, Thrombosis Reduction, Drug Delivery Devices Biopharmaceutical, Enzyme Delivery, Thrombolysis, Orphan Disease, Microvascular Thrombosis, Thrombotic Thrombocytopenic Purpura (TTP), Heart Attack, Stroke, Medical Innovation, Life-Threatening Conditions
Website
interfacebiologics.com targedbiopharmaceuticals.com
Interface Biologics logo

About Interface Biologics

Interface Biologics is a Canadian startup founded in 2001 that focuses on developing transformative biomedical polymer technology to enhance the safety and effectiveness of medical devices. Its primary technology areas include anti-thrombogenic additives that reduce thrombosis in blood-contacting me...

TargED Biopharmaceuticals logo

About TargED Biopharmaceuticals

TargED Biopharmaceuticals, founded in September 2018, is a promising player in the biopharma and biotechnology sectors, headquartered in The Netherlands. With the slogan "Targeted Enzyme Delivery to improve thrombolysis", TargED is focusing on a novel treatment avenue with its leading product, MICRO...

We will tell you when either one moves

BounceWatch watches Interface Biologics and TargED Biopharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Interface Biologics and TargED Biopharmaceutic... — by email.

Frequently Asked Questions

Interface Biologics. TargED Biopharmaceuticals — Targeted Enzyme Delivery to improve thrombolysis. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Interface Biologics has raised $32.00M while TargED Biopharmaceuticals has raised $61.85M.
Interface Biologics and TargED Biopharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Interface Biologics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Interface Biologics on 12 Sep 2024, and TargED Biopharmaceuticals on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes